Comparative Effectiveness of Two Initial Combination Therapies in Patients With Recent Onset Diabetes
A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 256 participants.
Also called NCT06246799
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose other
- Phase
- Phase 3
- Enrolled
- 256 participants
- Sponsor
- Registry
-
NCT06246799
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Recruiting
Technical summary
Registry record NCT06246799. Randomized; no masking; primary purpose other. Start 2024-11-07 (actual); primary completion 2029-04-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Comparative Effectiveness of Two Initial Combination Therapies in Patients With Recent Onset Diabetes
- Condition
- Type 2 Diabetes (Adult Onset)
- Intervention (Drug)
- Tirzepatide
- Intervention (Drug)
- Pioglitazone
- Intervention (Drug)
- Sitagliptin
- Intervention (Drug)
- Metformin HCI XR
- Lead sponsor
- The University of Texas Health Science Center at San Antonio
- Collaborator
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Record details
- Record id
cardio:ct-nct06246799- Content hash
ecfc2f101d8b3a07d1370a47cd2cc3cedee533c5f118c39a3c49768051942160